The Highly Regulated Environment of Medical Devices and the Problems of Commoditization

    

Who is it for?

General managers and senior managers with budget responsibility. 

What business issues will we address?

While payers shift attention from “price per device” to “price for therapy” and rental models of payment to control costs, regulators move towards evidence-based medicine and disease management. Changes in purchasing by hospitals and the involvement of medical practitioners in purchasing decisions make the Medtech business a difficult and challenging market. How can you best maneuver YOUR future products through the approval process and ensure that you business strategy incorporates it?

What will I be able to do after participating?

You will be better able to:

• Identify drivers of commoditization in CAPEX and consumable medical devices
• Select strategies to defend your products against commoditization
• Recognize opportunities and limits of your influence with regulatory and reimbursement authorities
• Create business models and product portfolios that reflect payers’ payment metrics
• Quantify and demonstrate service value to customers